# US 2026/0226566 A1 · Loop-Mediated Synthetic Riboregulators

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0226566 A1
- Document ID: US20260226566A1
- Status: Published application
- Kind: A1
- Application number: 19/412,505
- Filed: 2025-12-08
- Published: 2026-08-06
- Earliest claimed: 2016-08-04
- Assignees: Arizona Board of Regents on behalf of Arizona State University
- Applicants: Arizona Board of Regents On Behalf of Arizona State University
- Inventors: Alexander Green; Duo Ma
- Web page: https://patentgrep.com/patent/US20260226566A1

## CPC

- C12Q 1/6897: involving reporter genes operably linked to promoters
- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- C12N 15/63: Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N 15/67: General methods for enhancing the expression
- C12Q 1/68: involving nucleic acids
- C12Q 1/6809: Methods for determination or identification of nucleic acids involving differential detection
- C12Q 1/6816: characterised by the detection means (C12Q1/6804 takes precedence)
- C12Q 1/689: for bacteria
- C12Q 1/70: involving virus or bacteriophage {(immunoassay for viruses G01N33/56983)}
- C12N 2310/531: Stem-loop; Hairpin
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Provided herein are synthetic nucleic acid molecules known as loop-mediated riboregulators that have single-nucleotide polymorphism (SNP) sensitivity and ultralow OFF state signal levels. Loop-mediated riboregulators can activate or repress gene expression in response to trigger RNAs bearing completely arbitrary sequences. Also provided herein are methods of using such synthetic nucleic acid molecules for detecting the presence or absence of a particular target RNA in, for example, a biological sample.

## Claims

### Claim 1

A method of detecting presence of an endogenous RNA in a cell, the method comprising:
introducing into the cell a loop-mediated riboregulator comprising a synthetic nucleic acid molecule, the synthetic nucleic acid molecule comprising:
(a) a stem-loop structure, the stem-loop structure comprising:
a first stem-forming domain;
a loop-forming domain after the final 3′ nucleotide of the first stem-forming domain; and
a second stem-forming domain after the final 3′ nucleotide of the loop domain;
the second stem-forming domain comprising a ribosomal binding site (RBS), a translational start codon, and a 6 nucleotide clamp;
wherein the loop domain and a portion of the first stem-forming domain form an endogenous RNA docking site that is complementary to the endogenous RNA; and
(b) a coding sequence located downstream of the start codon;
wherein the second stem-forming domain is substantially complementary to the first stem-forming domain;
wherein the coding sequence encodes a reporter protein;
wherein the 6 nucleotide clamp in the second stem-forming domain corresponds to the first 6 nucleotides of the coding sequence; and
wherein the coding sequence does not comprise a linker;
culturing the cell under conditions that allow translation of the reporter protein in the presence of the endogenous RNA but not in the absence of the endogenous RNA; and
detecting the reporter protein as an indicator of the endogenous RNA in the cell.

### Claim 2

A method for altering expression of a target gene product in a cell, the method comprising
introducing into the cell a sequence encoding a loop-mediated riboregulator comprising a synthetic nucleic acid molecule, the synthetic nucleic acid molecule comprising:
(a) a stem-loop structure, the stem-loop structure comprising:
a first stem-forming domain;
a loop-forming domain after the final 3′ nucleotide of the first stem-forming domain; and
a second stem-forming domain after the final 3′ nucleotide of the loop domain;
the second stem-forming domain comprising a ribosomal binding site (RBS), a translational start codon, and a 6 nucleotide clamp;
wherein the loop domain and a portion of the first stem-forming domain form a trigger RNA docking site that is complementary to a trigger RNA; and
(b) a coding sequence located downstream of the start codon;
wherein the second stem-forming domain is substantially complementary to the first stem-forming domain;
wherein the coding sequence encodes the target gene product;
wherein the 6 nucleotide clamp in the second stem-forming domain corresponds to the first 6 nucleotides of the coding sequence;
wherein the coding sequence does not comprise a linker; and
wherein, in the presence of the trigger RNA in the cell, expression of the target gene product is altered.

### Claim 3 (depends on 1)

The method of claim 1, wherein the fold-change in expression of the target gene product is at least 25 fold.

### Claim 4 (depends on 1)

The method of claim 1, wherein the fold-change in expression of the target gene product is at least 50 fold.

### Claim 5 (depends on 1)

The method of claim 1, wherein, in the absence of the trigger RNA, OFF state expression levels of the target gene product are unchanged relative to a cell into which the loop-mediated riboregulator is not introduced.

### Claim 6 (depends on 1)

The method of claim 1, wherein the loop-mediated riboregulator is a loop-mediated repressor and expression of the target gene product is reduced relative to a cell into which the loop-mediated repressor is not introduced.

### Claim 7 (depends on 6)

The method of claim 6, wherein the reduction is at least 50-fold.

### Claim 8 (depends on 6)

The method of claim 6, wherein the reduction is at least 80-fold.

### Claim 9 (depends on 1)

The method of claim 1, wherein detecting the endogenous RNA molecule is a positive indicator of a presence of a microorganism, pathogen, or gene in said sample.

### Claim 10 (depends on 9)

The method of claim 9, wherein the microorganism or pathogen is selected from the group consisting of HIV, Zika virus, norovirus, Yellow fever virus, and Plasmodium falciparum.

### Claim 11 (depends on 1)

The method of claim 1, wherein detecting the endogenous RNA molecule is a negative indicator of a presence of a microorganism, pathogen, or gene in said sample.

### Claim 12 (depends on 11)

The method of claim 11, wherein the microorganism or pathogen is selected from the group consisting of HIV, Zika virus, norovirus, Yellow fever virus, and Plasmodium falciparum.
